title: Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.
abstract: Ubiquitination-mediated degradation of the RelA subunit of nuclear factor-kappaB (NF-kappaB) is critical for the termination of NF-kappaB activation. However, the precise mechanism for the ubiquitination of RelA is still not fully understood. Here we report that tumor necrosis factor-alpha (TNFalpha) induces RelA polyubiquitination at the lysine 195 residue, and this ubiquitination event is critical for the degradation of RelA and termination of TNFalpha-mediated NF-kappaB activation. Overexpression of a RelA mutant with an arginine substitution for the lysine 195 residue dramatically inhibits RelA polyubiquitination and induces a stronger NF-kappaB activation compared with the wild type. Reconstitution of RelA-deficient mouse embryo fibroblast cells with wild-type RelA or RelA containing a K195R mutation revealed the importance of this site in TNFalpha-mediated RelA polyubiquitination, degradation, and attenuation of NF-kappaB activation. Our finding is the first report that substitution of a key RelA lysine residue with arginine inhibits TNFalpha-induced RelA ubiquitination and enhances TNFalpha-induced NF-kappaB activation.
authors.affiliation: Department of Pediatrics, Texas Children's Cancer Center, Houston, TX 77030, USA.
authors.forename: Yihui
authors.initials: Y
authors.lastname: Fan
authors.forename: Renfang
authors.initials: R
authors.lastname: Mao
authors.forename: Yanling
authors.initials: Y
authors.lastname: Zhao
authors.forename: Yang
authors.initials: Y
authors.lastname: Yu
authors.forename: Wenjing
authors.initials: W
authors.lastname: Sun
authors.forename: Ping
authors.initials: P
authors.lastname: Song
authors.forename: Zhongcheng
authors.initials: Z
authors.lastname: Shi
authors.forename: Dekai
authors.initials: D
authors.lastname: Zhang
authors.forename: Eric
authors.initials: E
authors.lastname: Yvon
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.forename: Songbin
authors.initials: S
authors.lastname: Fu
authors.forename: Jianhua
authors.initials: J
authors.lastname: Yang
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D002460:Cell Line; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D006801:Humans; D008239:Lysine / Q000235:genetics / Q000378:metabolism; D051379:Mice; D020125:Mutation, Missense; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D051996:Transcription Factor RelA / Q000235:genetics / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000494:pharmacology*; D054875:Ubiquitination / Q000187:drug effects / Q000502:physiology*
chemical_list: D016328:NF-kappa B; C498143:RELA protein, human; C498144:Rela protein, mouse; D051996:Transcription Factor RelA; D014409:Tumor Necrosis Factor-alpha; D008239:Lysine
references.citation: Genes Dev. 2009 Apr 1;23(7):849-61
references.pmid: 19339690
references.citation: Mol Cell. 2003 Dec;12(6):1413-26
references.pmid: 14690596
references.citation: Sci Signal. 2008 Jan 08;1(1):pe1
references.pmid: 18270169
references.citation: Science. 2007 Aug 3;317(5838):675-8
references.pmid: 17673665
references.citation: Genes Dev. 1995 Nov 15;9(22):2723-35
references.pmid: 7590248
references.citation: Nature. 1995 Jul 13;376(6536):167-70
references.pmid: 7603567
references.citation: Genes Dev. 2004 Sep 15;18(18):2195-224
references.pmid: 15371334
references.citation: Mol Cell Biol. 1990 May;10(5):2327-34
references.pmid: 2183031
references.citation: J Exp Med. 2004 Jul 5;200(1):107-13
references.pmid: 15226358
references.citation: J Biol Chem. 2008 Sep 5;283(36):24497-505
references.pmid: 18617512
references.citation: Genes Dev. 1993 Nov;7(11):2064-70
references.pmid: 8224838
references.citation: EMBO J. 2009 May 6;28(9):1283-95
references.pmid: 19322197
references.citation: Mol Cell Biol. 1990 Feb;10(2):561-8
references.pmid: 2405250
references.citation: EMBO J. 2007 Jan 24;26(2):436-47
references.pmid: 17183367
references.citation: EMBO Rep. 2009 Apr;10(4):381-6
references.pmid: 19270718
references.citation: Sci STKE. 1999 Oct 26;1999(5):RE1
references.pmid: 11865184
references.citation: Nat Immunol. 2007 Jun;8(6):584-91
references.pmid: 17468759
references.citation: Mol Cell Biol. 1990 Jul;10(7):3818-23
references.pmid: 2192263
references.citation: Cell Signal. 2009 Jan;21(1):95-102
references.pmid: 18930133
references.citation: Annu Rev Immunol. 1996;14:649-83
references.pmid: 8717528
references.citation: Trends Immunol. 2008 Oct;29(10):469-78
references.pmid: 18775672
references.citation: Immunol Today. 1998 Feb;19(2):80-8
references.pmid: 9509763
references.citation: Nature. 2005 Apr 28;434(7037):1138-43
references.pmid: 15858576